Skip to content
Call Us Today! 1 (772) 595-9830 info@midwayresearch.com
Facebook
Twitter
LinkedIn
Instagram
Home
About
Clinical Trials
Currently Enrolling Studies
Active, not recruiting Studies
What is a Clinical Trial?
Expectations
Studies Phases
Informed Consent
Closed Studies
Services
HIV
STD
HPV
Lipodystrophy
Journal Publications
Contact
Home
About
Clinical Trials
Currently Enrolling Studies
Active, not recruiting Studies
What is a Clinical Trial?
Expectations
Studies Phases
Informed Consent
Closed Studies
Services
HIV
STD
HPV
Lipodystrophy
Journal Publications
Contact
Currently Enrolling Studies
Home
/
Currently Enrolling Studies
Currently Enrolling Studies
jsukhram
2022-01-17T20:59:02+00:00
1
Recruiting
Study to evaluate the efficacy and safety of pritelivir versus foscarnet for HSV subjects resistant to Acyclovir
HSV Infection
Drug: Pritelivir
Drug: Foscarnet
Check Eligibility
2
Recruiting
A Phase 1b, OL Study to Evaluate the PK, Safety & Efficacy of Biktarvy in HIV-1 infected, Virologically Suppressed, Pregnant Women in their Second and Third Trimesters-HIV RNA < 50 copies for > 6 months, GFR > 90, No HBV
HIV-1 Infection
Drug: B/F/TAF
Check Eligibility
3
Recruiting
A Phase 4, Randomized, Active-controlled, Open-label Study to Evaluate the Tolerability of Switching to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/FAF) Once Daily Fixed-dose Combination (FDC) Regimen
HIV-1 Infection
Drug: D/C/F/TAF FDC
Drug: TAF/FTC FDC
Drug: INI Based Regimen
Check Eligibility
4
Recruiting
Acute Hepatitis C (HCV) Infections: Safety and Efficacy of Glecaprevir (GLE)/Pibrentasvir (PIB)
Hepatitis C Virus
Drug: Glecaprevir/ Pibrentasvir
Check Eligibility
5
Recruiting
A Phase IIb, randomized, double-blind, parallel-group study to assess the efficacy, safety, tolerability, and resistance profile of GSK3640254 in combination with dolutegravir compared to dolutegravir plus lamivudine in HIV-1 infected, treatment-naive adults
HIV-1 Infection
Drug: GSK3640254
Drug: Dolutegravir
Drug: Lamivudine Capsules
Drug: Lamivudine Tablets
Check Eligibility
6
Recruiting
A Randomized, Double-blind, Placebo-controlled, Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple “Doses of ABBV-181 in HIV-1 infected Adults
HIV-1 Infection
Drug: ABBV-181
Drug: Placebo
Check Eligibility
7
Recruiting
A Phase 1b Study to Evaluate the Safety and Tolerability of GS-1966/GS-1144 HIV Vaccine Regimens in Antiretroviral Treated People with HIV-1
HIV-1 Infection
Check Eligibility
8
Recruiting
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ABBV-382 in Persons Living with HIV-1
HIV-1 Infection
Drug: ABBV-382
Drug: Placebo for ABBV-382
Check Eligibility